Cardiff Oncology (CRDF) Total Current Liabilities (2016 - 2025)
Cardiff Oncology (CRDF) has disclosed Total Current Liabilities for 15 consecutive years, with $16.4 million as the latest value for Q4 2025.
- Quarterly Total Current Liabilities rose 22.09% to $16.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.4 million through Dec 2025, up 22.09% year-over-year, with the annual reading at $16.4 million for FY2025, 22.09% up from the prior year.
- Total Current Liabilities hit $16.4 million in Q4 2025 for Cardiff Oncology, up from $14.7 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $16.7 million in Q2 2025 to a low of $4.5 million in Q1 2021.
- Historically, Total Current Liabilities has averaged $10.0 million across 5 years, with a median of $9.1 million in 2023.
- Biggest five-year swings in Total Current Liabilities: fell 8.24% in 2021 and later surged 85.22% in 2022.
- Year by year, Total Current Liabilities stood at $6.6 million in 2021, then increased by 19.04% to $7.8 million in 2022, then skyrocketed by 33.71% to $10.4 million in 2023, then grew by 28.62% to $13.4 million in 2024, then grew by 22.09% to $16.4 million in 2025.
- Business Quant data shows Total Current Liabilities for CRDF at $16.4 million in Q4 2025, $14.7 million in Q3 2025, and $16.7 million in Q2 2025.